SEC Form 4 · accession 0000939767-16-000288

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

George A Scangos

Director

Period of report

Dec 5, 2016

Accepted (ET)

Dec 7, 2016 · 7:03 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 5, 2016	M	357,976	$8.99	A	1,668,186	D
Common Stock^F2	Dec 5, 2016	S	204,718	$17.81	D	1,463,468	D
Common Stock	Dec 7, 2016	M	356	$8.99	A	1,463,824	D
Common Stock	Dec 7, 2016	S	176	$17.90	D	1,463,648	D
Common Stock^F3	holding	—	—		—	8,963	I	By Trust (JS)
Common Stock^F4	holding	—	—		—	8,963	I	By Trust (KS)
Common Stock^F5	holding	—	—		—	5,669	I	By 401(k) Plan

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F6	$8.99	Dec 5, 2016	M	357,976	D	Dec 8, 2007	Dec 7, 2016	Common Stock	357,976	356	D
Option (right to buy)^F6	$8.99	Dec 7, 2016	M	356	D	Dec 8, 2007	Dec 7, 2016	Common Stock	356	0	D

Explanation of responses

F1Includes 1,596 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.45 to $18.00. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
F4Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
F5Represents 5,669 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 2, 2016.
F6The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to 100,000 shares on December 8, 2007, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the original grant date (December 8, 2006). The option ceased vesting on July 15, 2010, in connection with the Reporting Person's resignation as President and Chief Executive Officer of Exelixis, Inc., at which time the option was exercisable as to as to 358,332 shares of Exelixis, Inc. Common Stock.